The study of the role of miR-221-3p and the interaction with its target, PARP-1, during COVID-19 pathogenesis would be of great interest, since emerging evidence highlights relevant pro and antiviral properties of this protein (38). This evidence concerns the gene PARP1 and COVID-19.